2011 Molecular Imaging Journal Club
Day & Time: Thursday 12:00-1:00pm
Location: Edwards Seminar Room R358
Cycle: weekly alternation between clinical and basic science
Guidelines: Download the guidelines [ MS Word | PDF ]
You will need the free Adobe Acrobat Reader plugin to view the abstracts. Click on the icon 
under the date to download the abstract.
| Date | Title | Lab/Clinic | Presenter |
|---|---|---|---|
| Dec 8, 2011 |
Mallidi S, Luke GP, Emelianov S. Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance. Trends Biotechnol. 2011 May;29(5):213-21. | Lab | Dominique van de Sompel, PhD |
| Nov 10, 2011 |
Kunikowska J, Królicki L, Hubalewska-Dydejczyk A, Mikołajczak R, Sowa-Staszczak A, Pawlak D. Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?. Eur J Nucl Med Mol Imaging. 2011 Oct;38(10):1788-97. | Clinical | Camila Mosci, MD |
| Oct 13, 2011 |
Rouzet F, Bachelet-Violette L, Alsac JM, Suzuki M, Meulemans A, Louedec L, Petiet A, Jandrot-Perrus M, Chaubet F, Michel JB, Le Guludec D, Letourneur D. Radiolabeled fucoidan as a p-selectin targeting agent for in vivo imaging of platelet-rich thrombus and endothelial activation. J Nucl Med. 2011 Sep;52(9):1433-40. | Clinical | Sami Akram, MD |
| Sept 29, 2011 |
Kruger RA, Lam RB, Reinecke DR, Del Rio SP, Doyle RP. Photoacoustic angiography of the breast. Med Phys. 2010 Nov;37(11):6096-100. | Lab | Raj Kothapalli, PhD |
| Sept 15, 2011 |
How to Present at Journal Club. | Lab | David Dick, PhD |
| June 30, 2011 | Heskamp S, van Laarhoven HW, Molkenboer-Kuenen JD, Franssen GM, Versleijen-Jonkers YM, Oyen WJ, van der Graaf WT, Boerman OC. ImmunoSPECT and immunoPET of IGF-1R expression with the radiolabeled antibody R1507 in a triple-negative breast cancer model. JNM 2010;51(10):1565-72. | Lab | Arut Natarajan, PhD |
| June 2, 2011 |
Fischer T, Thomas A, Tardy I, Schneider M, Hünigen H, Custodis P, Beyersdorff D, Plendl J, Schnorr J, Diekmann F, Gemeinhardt O. Vascular endothelial growth factor receptor 2-specific microbubbles for molecular ultrasound detection of prostate cancer in a rat model. Invest Radiol. 2010;45(10):675-84. | Lab | Kira Foygel, PhD |
| May 19, 2011 |
Schoffelen R, Sharkey RM, Goldenberg DM, Franssen G, McBride WJ, Rossi EA, Chang CH, Laverman P, Disselhorst JA, Eek A, van der Graaf WT, Oyen WJ, Boerman OC. Pretargeted ImmunoPET Imaging of CEA-expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-labeled Hapten-peptide in Mice with Human Tumor Xenografts. Mol Cancer Ther. 2010 Apr;9(4):1019-27. | Lab | Ben Hackel, PhD |
| May 5, 2011 |
Holland JP, Divilov V, Bander NH, Smith-Jones PM, Larson SM, Lewis JS. 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo. J Nucl Med. 2010 Aug;51(8):1293-300. | Lab | Eric Gonzalez, PhD |
| Apr 21, 2011 |
Grandpierre S, Desandes E, Meneroux B, Djaballah W, Mandry D, Netter F, Wahl D, Fay R, Karcher G, Marie PY. Arterial Foci of F-18 Fluorodeoxyglucose Are Associated With an Enhanced Risk of Subsequent Ischemic Stroke in Cancer Patients: A Case-Control Pilot Study. Clin Nucl Med. 2011 Feb;36(2):85-90. | Clinical | Sami Akram, MD |
| Apr 7, 2011 Supplement |
Spires-Jones TL, Calignon A, Meyer-Luehmann M, Bacskai BJ, Hyman BT. Monitoring protein aggregation and toxicity in Alzheimer's disease mouse models using in vivo imaging. Methods. 2011 Mar;53(3):201-7. | Lab | Hua Fan-Minogue, MD, PhD |
| Mar 17, 2011 |
Kuliszewski MA, Kobulnik J, Lindner JR, Stewart DJ, Leong-Poi H. Vascular Gene Transfer of SDF-1 Promotes Endothelial Progenitor Cell Engraftment and Enhances Angiogenesis in Ischemic Muscle. Mol Ther. 2011. | Lab | Beth Pysz, PhD |
| Mar 3, 2011 |
Lin Y, Cheung P, Roth JC, Wilson DL, Gerson SL. Imaging Stem Cell-derived Persistent Foci After In Vivo Selection of Lentiviral MGMT-P140K Transduced Murine Bone Marrow Cells. Mol Ther. 2011. | Lab | Patricia de Almeida, PhD |
| Feb 17, 2011 |
van Duijnhoven SM, Robillard MS, Nicolay K, Grüll H. Tumor Targeting of MMP-2/9 Activatable Cell-Penetrating Imaging Probes Is Caused by Tumor-Independent Activation. JNM. 2011;52(2):279-86. | Clinical | Ed Wong, MD |
| Feb 3, 2011 |
Melis M, de Swart J, de Visser M, Berndsen SC, Koelewijn S, Valkema R, Boerman OC, Krenning EP, de Jong M. Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy. JNM. 2010;51(12):1962-8. | Lab | Susan Hoppmann, PhD |
| Jan 20, 2011 |
Moy L, Noz ME, Maguire GQ Jr, Melsaether A, Deans AE, Murphy-Walcott AD, Ponzo F. Role of fusion of prone FDG-PET and magnetic resonance imaging of the breasts in the evaluation of breast cancer. Breast J. 2010 Jul-Aug;16(4):369-76. | Lab | Farhad Taghibakhsh |
| Jan 6, 2011 |
Sugahara KN, Teesalu T, Karmali PP, Kotamraju VR, Agemy L, Greenwald DR, Ruoslahti E. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science. 2010 May 21;328(5981):1031-5. | Lab | Zheng Miao |
